DUROLANE, GELSYN-3 and SUPARTZ FX are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen. Risks include general knee pain and pain at injection site.
View Use and Important Safety Information at: DUROLANE.com, GELSYN3.com, and SUPARTZFX.COM
Summary of Indications for Use:
DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.
Do not inject DUROLANE in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations. Risks can include transient pain or swelling at the injection site.
DUROLANE has not been tested in pregnant or lactating women, or children.
Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.
Summary of Indications for Use:
GELSYN-3 is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.
GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.
Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.
Summary of Indications for Use:
SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.
Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
| Cookie name | Description | Cookie Type | Expiration |
| _ga | Registers a unique ID that is used to generate statistical data on how the visitor uses the website. | Statistic | 2 years |
| _gat | Used by Google Analytics to throttle request rate | Statistic | 1 day |
| _gid | Registers a unique ID that is used to generate statistical data on how the visitor uses the website. | Statistic | 1 day |
| Used to measure the effectiveness of Facebook ads, define custom audiences for ad targeting, dynamic ads campaigns, and analyze the effectiveness of the website’s conversion funnels. Uses first-party and third-party cookies. | Marketing | 180 days | |
| spu_closing | Stores information if a popup window was closed. | Marketing | 30 days |
Please enable Strictly Necessary Cookies first so that we can save your preferences!
